Characterization of a new rat model for chronic inflammatory demyelinating polyneuropathies
- PMID: 25595246
- DOI: 10.1016/j.jneuroim.2014.11.022
Characterization of a new rat model for chronic inflammatory demyelinating polyneuropathies
Abstract
Our objective was to develop a chronic model of EAN which could be used as a tool to test treatment strategies for CIDP. Lewis rats injected with S-palmitoylated P0(180-199) peptide developed a chronic, sometimes relapsing-remitting type of disease. Our model fulfills electrophysiological criteria of demyelination with axonal degeneration, confirmed by immunohistopathology. The late phase of the chronic disease was characterized by accumulation of IL-17(+) cells and macrophages in sciatic nerves and by high serum IL-17 levels. In conclusion, we have developed a reliable and reproducible animal model resembling CIDP that can now be used for translational drug studies.
Keywords: Animal model; CIDP; Chronic EAN; Electrophysiology; Immunology; Sciatic nerve immunohistochemistry; Thiopalmitoylated P0 peptide.
Copyright © 2014 Elsevier B.V. All rights reserved.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
